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Abstract
Previous outbreaks suggest that pregnant women with Ebola virus disease (EVD) are at increased 
risk for severe disease and death. Healthcare workers who treat pregnant women with EVD are at 
increased risk of body fluid exposure. Despite the absence of pregnant women with EVD in the 
United States, CDC activated the Maternal Health Team (MHT), a functional unit dedicated to 
emergency preparedness and response issues, on October 18, 2014. We describe major activities of 
the MHT. A high-priority MHT activity was to publish guiding principles early in the response. 
The MHT also prepared guidance documents, provided guidance and technical support for 
hospital preparedness, and addressed inquiries. We analyzed maternal health inquiries received 
through CDC-INFO, MHT, and CDC’s Medical Investigations Team from August 2014 to 
December 2015. Internal call logs used to capture, monitor, and track inquiries for the three data 
sources were merged. Inquiries not related to maternal health issues and duplicates were removed. 
Each inquiry was categorized by route (email/phone), inquirer type, and topic. In total, 201 
inquiries were received from clinicians, public health professionals, and the public. The 
predominant topic was related to infection control for high-risk situations such as labor and 
delivery. During the Ebola response, most inquiries were received via email rather than telephone, 
a notable shift compared to the H1N1 emergency response. Lessons learned during the H1N1 and 
Ebola responses are currently informing CDC’s Zika Response, an unprecedented emergency 
response primarily focused on reproductive health issues.
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Purpose
The largest Ebola virus epidemic in history occurred in West Africa from March 2014 to 
December 2015.1,2 More than 28,000 cases were reported; of those, more than 11,000 died. 
The overwhelming majority of cases and deaths occurred in Guinea, Liberia, and Sierra 
Leone. An additional 36 travel-related cases were reported in 6 other countries, including the 
United States.1 This challenging global public health emergency led to the largest 
emergency response in CDC’s history and included participation of ~4000 CDC staff 
members in both international and domestic efforts.2
The first case of Ebola in the United States was diagnosed in September 2014. In total, four 
patients were diagnosed with Ebola virus disease (EVD) in the United States, including two 
healthcare workers who cared for the first U.S. patient. An additional seven patients with 
EVD were transported from West Africa to the United States for care and treatment.2 The 
introduction of Ebola into the United States and subsequent transmission to healthcare 
workers served as a warning to the U.S. public health, medical, and hospital systems. As a 
result, CDC embarked on a vigorous emergency preparedness agenda within the United 
States.3 While the overall U.S. response included preparation for all types of Ebola patients, 
we will focus on those related to maternal health.
There is limited evidence regarding EVD in pregnancy because historically, Ebola outbreaks 
have occurred in resource-limited areas where information about pregnancy has not been 
systematically collected.4 Previous outbreaks suggest that pregnant women with EVD are 
more likely than the general population to have severe disease and die. Compared to women 
without EVD, they may be at higher risk for spontaneous abortion and hemorrhage, and 
their infants are not likely to survive. In addition, healthcare workers who treat pregnant 
women with EVD are at an increased risk of body fluid exposure when attending to women 
during the labor and delivery process.
Despite the absence of pregnant women with EVD in the United States, the CDC’s Division 
of Reproductive Health (DRH) mobilized the Maternal Health Team (MHT) on October 18, 
2014, as part of the agency’s emergency response to address maternal health issues in the 
United States and internationally. In this article, we focus on the domestic response. We 
describe major activities of the MHT, including a timeline of events, inquiries received 
pertaining to maternal health, and publication of guidance documents and articles. We 
believe that sharing this experience can inform the routine inclusion of an MHT as a key 
component of any future emergency responses.
Description
The CDC Emergency Operations Center (EOC) was activated on July 9, 2014, and the WHO 
declared Ebola a public health emergency on August 7, 2014.2 The EOC is the onsite 
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command center for coordinating emergency responses to domestic and international public 
health threats.5 Initially, the EOC managed clinical inquiries until the volume of inquiries 
exceeded staffing capacity and there was a need for special expertise, particularly as 
questions increased about the impact of EVD on pregnancy and delivery and the risk to 
healthcare providers attending to pregnant women. While the experts representing the MHT 
had provided technical expertise to the response since EOC activation, the MHT was 
formally activated on October 18, 2014. This is the second time that the MHT was activated 
as part of an emergency response; the initial activation was during the 2009–2010 Pandemic 
H1N1 Influenza response.6 The Ebola outbreak in West Africa officially ended in December 
2015 when Guinea was declared Ebola free.1 On March 29, 2016, WHO declared that the 
Ebola outbreak in West Africa no longer constituted a public health emergency. 
Subsequently, the EOC activation for CDC’s Ebola response ended on March 31, 2016.2
The MHT in DRH is a functional unit that works on emergency preparedness issues related 
to reproductive health, and includes maternal child health experts from across the agency. It 
can quickly scale up and expand response capacity for events that disproportionately affect 
pregnant women and women with infants. This is referred to as MHT activation. During 
CDC’s Ebola Response, MHT subject matter experts (SMEs) continuously provided clinical 
and epidemiologic expertise to response-related scientific and epidemiologic activities. 
While the MHT officially deactivated on February 22, 2015, DRH scientists continued to 
respond to the needs of U.S. healthcare organizations through activities such as serving on 
the EOC Healthcare Domestic Infection Control Training Team, being deployed to a state 
health department to assist with Ebola inquiries, and assisting with Rapid Ebola 
Preparedness training for labor and delivery. Furthermore, while no women in the United 
States had Ebola during pregnancy, CDC Emergency Response Teams (CERT) have been 
deployed to assist U.S. local hospitals with deliveries of Ebola virus survivors.7
A high-priority MHT activity during CDC’s Ebola response was to publish guiding 
principles for pregnant women early in the response. These guiding principles assessed the 
following: whether pregnant women were more susceptible to infection with Ebola virus 
than the general population; if pregnant women with EVD were at an increased risk for 
severe illness and mortality compared to the general population; if EVD during pregnancy 
was associated with adverse pregnancy outcomes; and special considerations for maternal 
treatment and prophylaxis. Guiding principles were based on a critical review of what was 
currently known about EVD and its effects on pregnant women, and were disseminated 
through an article titled “What obstetrician-gynecologist should know about Ebola.”4
The MHT also prepared guidance documents, provided technical assistance for Rapid Ebola 
Preparedness visits to U.S. hospitals, and addressed inquiries related to Ebola and maternal 
health.8–10 The MHT developed several scientific products, including four peer-reviewed 
journal articles and a case report concerning a pregnant patient with Ebola in Sierra Leone 
(Table 1).
To inform future responses, we analyzed maternal health inquiries that were addressed by 
the MHT during the activation of the Ebola response (similar to the analyses of inquiries 
received during the Pandemic H1N1 response).6 Analyses of maternal health inquiries 
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received during the response highlighted needs of the U.S. pregnant population and salient 
questions asked by medical and public health professionals and the general public.
Assessment
Inquiries to the CDC are received by CDC-INFO, the national contact center that provides 
science-based health information to the public, healthcare providers, and public health 
professionals either by phone or email. In an emergency response, some inquiries require 
input from SMEs. Consequently, CDC-INFO staff escalate these inquiries to the EOC for 
further assessment and review. Inquiries related to pregnant/postpartum women and infants 
are sent to the MHT for topic-specific expertise. Inquiries were also received via the CDC 
Medical Investigations Team. This team of clinicians was established to address questions 
from State Health Departments and healthcare providers regarding suspected cases of Ebola, 
including those returning from Ebola-affected countries. A phone line was also created to 
provide testing consultations when EVD was suspected and recommendations on screening 
for Ebola based on symptoms and epidemiologic risk factors. The Medical Investigations 
Team used CDC guidance and prepared responses to answer these inquiries. If there was no 
CDC-published guidance to answer the inquiry, then the inquiry was escalated to the EOC 
response team (e.g., MHT). The MHT provided technical assistance for escalated clinical 
inquiries for the duration of the CDC response.
We analyzed inquiries on maternal health issues received through CDC-INFO, MHT, and the 
Medical Investigations Team from August 2014 to December 2015, when the outbreak was 
declared over in West Africa. Internal call logs used to capture, monitor, and track inquiries 
for the three data sources were merged. Duplicate inquiries and those not related to maternal 
health issues were removed. After reviewing 522 inquiries, 201 entries met our selection 
criteria for inclusion in our analysis (Fig. 1). We analyzed inquiries related to pregnant and 
postpartum women, neonates, and healthcare workers in obstetric settings.
Each inquiry was categorized by route of inquiry, inquirer type, and topic area. The 
following major topics were used: antiviral prophylaxis/treatment, breastfeeding/nutrition 
guidelines, clinical, epidemiology, infection control, screening/testing for Ebola. and 
vaccine. Some topics were diverse enough that it was necessary to categorize into subtopics. 
A single inquiry could have more than one topic and subtopic. We also calculated the 
number of inquiries received by month.
Results
From August 2014 to December 2015, CDC-INFO received a total of 35,879 Ebola 
inquiries, and <1.0% (n = 108) were related to maternal health issues. Of the 201 inquiries 
received, 65% were received by email with the remainder by phone (35%). The majority of 
inquiries (85%) were received during 5 months of the MHT activation, October, 2014–
February, 2015. Most of the inquiries came from clinicians (68%) and the general public 
(20%) (Table 2). Over half of the inquiries (54%) were received through CDC-INFO, and 
about a third (39%) were received directly by the MHT (Table 2).
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The 201 inquiries received covered 258 unique topics. Of the total topics covered, more than 
half related to infection control (57%) and nearly a third related to clinical topics (30%). 
Fewer inquiry topics were related to breastfeeding/nutrition guidelines (7%), epidemiology 
(3%), or screening/testing for Ebola (3%), only one inquiry was related to vaccines (<1%), 
and none were related to antiviral prophylaxis/treatment (Table 3).
The primary topic of inquiries through both CDC-INFO and the MHT was infection control 
(56% and 66%, respectively). About a third of the inquiries addressed by the Medical 
Investigations Team were on infection control (30.4%), whereas the majority (69.6%) 
received through this channel were clinical inquiries through the healthcare providers’ line.
As stated above, some topics were further divided into subtopics (Table 3). Among inquiries 
related to infection control (n = 147), most related to obstetric care risks (n = 75) and 
questions about risks to pregnant and breastfeeding healthcare workers (n = 53). In addition, 
most clinical inquiries (n = 76) related to guidance and management of pregnant women 
with EVD (n = 54) (Table 3).
Conclusion
The CDC MHT was formally activated in the domestic Ebola response on October 18, 2014. 
Due to a decrease in domestic inquiries, and an effort to refocus CDC Ebola response efforts 
in West Africa, the MHT was deactivated on February 22, 2015.
Substantially fewer inquiries were received during the Ebola response related to maternal 
health compared to the 2009 Pandemic H1N1 response.6 The reduction in inquiries is likely 
due to several factors, including the Ebola response being primarily internationally focused. 
In addition, this may be a result of increased preparedness efforts and rapid dissemination of 
guiding principles, resulting in less unanswered questions from healthcare providers and the 
public. A notable shift observed during the Ebola response was a reversal in the incoming 
channel for inquiries, with most received via email rather than telephone.6
The MHT faced many challenges throughout the Ebola response. This was the largest 
response in CDC’s history. As a result, many staff were deployed and unavailable to work 
specifically on maternal health issues. In addition, during an emergency, it is often difficult 
to get emergency responders and public health professionals to think about the unique needs 
of pregnant women and their infants. Little to no surveillance is conducted among this 
vulnerable population.11,12 This may be due to pregnant women making up just 1% of the 
general population and 5% of women of reproductive age at a given point in time in the 
United States, making it difficult to conduct population-based surveillance.
The MHT’s first activation for CDC’s Pandemic H1N1 response highlighted the needs of 
pregnant women during an influenza pandemic and the usefulness of disseminating health 
information via CDC’s website and social media.6 These lessons informed the MHT’s 
preparedness activities and response to the Ebola outbreak. Now, lessons learned from the 
Ebola response are currently informing CDC’s Zika virus response, an emergency response 
focusing on reproductive health. For CDC’s Zika response, the MHT joined colleagues from 
the National Center of Birth Defects and Developmental Disabilities and the National Center 
Ellington et al. Page 5
J Womens Health (Larchmt). Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
for Emerging and Zoonotic Infectious Diseases to create the Pregnancy and Birth Defects 
Task Force. This task force has been able to rapidly disseminate numerous scientific 
documents. For example, the MHT’s work on infection control in Ebola built the foundation 
for recommendations to prevent transmission of Zika virus in obstetric settings through 
implementation of standard precautions.13 With each emergency response and continued 
preparedness work, the MHT strives to advance the science around reproductive health and 
emergencies, and ultimately increase the health of women and infants.
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FIG. 1. 
Derivation of final samples of inquiries.
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Table 1
2014–2015 Scientific Products Developed by the Maternal Health Team
Scientific products Date of initial publication Page views/Citationsa
Guidance documents
  Recommendations for breastfeeding/infant feeding in the context of EVDb September 17, 2014 31,067c
  Guidance for screening and caring for pregnant women with Ebola in the United 
Statesb
November 1, 2014 21,623d
Articles
  What obstetricians—gynecologists should know about Ebola: a perspective from the 
Centers for Disease Control and Prevention4
September 9, 2014 48
  U.S. hospital preparedness for obstetric patients with possible Ebola10 February 3, 2015 1
  EVD: focus on children14 April 4, 2015 3
  Pregnancy, labor, and delivery after EVD and implications for infection control in 
obstetric services, United States7
July 15, 2016 2
Case report
  A pregnant patient with EVD15 September 17, 2015 5
aCitations from Google Scholar (www.scholar.google.com) as of November 30, 2016.
bComplete citations are in the reference list.
c
From September 17, 2015–September 13, 2016.
d
From November 1, 2015–September 13, 2016.
EVD, Ebola virus disease.
J Womens Health (Larchmt). Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Ellington et al. Page 9
Table 2
Maternal Health Inquiries by Inquirer and Channel of Inquiry, August 2014–December 2015
Inquirer
Channel of inquiry
CDC-
INFO
Maternal
heath team
Medical
investigations
team Total
N N N N (%)
Clinician 68 54 15 137 (68)
General public 40 1 0 41 (20)
CDC internal 0 17 0 17 (8)
Federal or state health partner 0 3 0 3 (1)
Media 0 3 0 3 (1)
Total N (%) 108 (54) 78 (39) 15 (7) 201
CDC-INFO, the national contact center that provides science-based health information by phone or email.
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Table 3
Topics and Subtopics of Maternal Health Inquiries, August, 2014–December, 2015 (N= 258)
Topics/subtopics n Percenta
Infection control 147 57
  Obstetric care/labor and delivery risk factors 75 29
  Pregnant and breastfeeding healthcare workers 53 21
  Travel/transport guidelines 20 8
  Infant guidelines 19 7
  Isolation of mother and newborn 10 4
Clinical 76 30
  Guidance/management of pregnant women with EVD 54 21
  Risks/symptoms/transmission 25 10
Breastfeeding 18 7
Screening/testing for Ebola 8 3
Epidemiology 8 3
  Research 5 2
  Mortality 1 <1
  Surveillance systems 2 1
Vaccine 1 <1
a
Percentages may be >100 because >1 subtopic was included per topic.
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